documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
16,156 rows where agency_id = "FDA" and posted_year = 2024 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date)
document_type 5
- Other 11,608
- Supporting & Related Material 3,653
- Notice 804
- Rule 61
- Proposed Rule 30
posted_year 1
- 2024 · 16,156 ✖
agency_id 1
- FDA · 16,156 ✖
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2022-N-2390-0097 | FDA | FDA-2022-N-2390 | Exhibit 208 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:29:54Z | 0 | 0 | 09000064868a2ef0 | |||
| FDA-2022-N-2390-0128 | FDA | FDA-2022-N-2390 | Exhibit 239 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:26:26Z | 0 | 0 | 09000064868a2f37 | |||
| FDA-2022-N-2390-0123 | FDA | FDA-2022-N-2390 | Exhibit 234 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:26:56Z | 0 | 0 | 09000064868a2f32 | |||
| FDA-2022-N-2390-0126 | FDA | FDA-2022-N-2390 | Exhibit 237 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:26:37Z | 0 | 0 | 09000064868a2f35 | |||
| FDA-2022-N-2390-0090 | FDA | FDA-2022-N-2390 | Exhibit 201 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:29:04Z | 0 | 0 | 09000064868a2ee9 | |||
| FDA-2022-N-2390-0096 | FDA | FDA-2022-N-2390 | Exhibit 207 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:29:48Z | 0 | 0 | 09000064868a2eef | |||
| FDA-2022-N-2390-0127 | FDA | FDA-2022-N-2390 | Exhibit 238 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:26:31Z | 0 | 0 | 09000064868a2f36 | |||
| FDA-2022-N-2390-0088 | FDA | FDA-2022-N-2390 | Exhibit 199 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:28:52Z | 0 | 0 | 09000064868a3103 | |||
| FDA-2022-N-2390-0103 | FDA | FDA-2022-N-2390 | Exhibit 214 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:32:27Z | 0 | 0 | 09000064868a2f07 | |||
| FDA-2022-N-2390-0115 | FDA | FDA-2022-N-2390 | Exhibit 226 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:14Z | 0 | 0 | 09000064868a2f1d | |||
| FDA-2022-N-2390-0101 | FDA | FDA-2022-N-2390 | Exhibit 212 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:32:37Z | 0 | 0 | 09000064868a2f05 | |||
| FDA-2022-N-2390-0107 | FDA | FDA-2022-N-2390 | Exhibit 218 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:32:05Z | 0 | 0 | 09000064868a2f0b | |||
| FDA-2022-N-2390-0120 | FDA | FDA-2022-N-2390 | Exhibit 231 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:30:47Z | 0 | 0 | 09000064868a2f2f | |||
| FDA-2024-H-5929-0001 | FDA | FDA-2024-H-5929 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-02T05:00:00Z | 2025-01-02T14:32:14Z | 0 | 0 | 090000648689709d | ||
| FDA-2000-N-0011-0028 | FDA | Uniform Compliance Date for Food Labeling Regulations FDA-2000-N-0011 | Uniform Compliance Date for Food Labeling Regulations | Rule | Final Rule | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2025-03-04T04:59:59Z | 2025-03-05T02:00:44Z | 2024-31419 | 0 | 0 | 0900006486896c8a |
| FDA-2024-N-3271-0002 | FDA | FDA-2024-N-3271 | Flamingo Pharmaceuticals Ltd.; Withdrawal of Approval of Two Abbreviated New Drug Applications | Notice | Withdrawal | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2024-12-31T14:36:36Z | 2024-31360 | 0 | 0 | 0900006486896c82 | |
| FDA-2024-H-5921-0001 | FDA | FDA-2024-H-5921 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2024-12-31T16:08:58Z | 0 | 0 | 090000648689712d | ||
| FDA-2022-N-2390-0105 | FDA | FDA-2022-N-2390 | Exhibit 216 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:32:18Z | 0 | 0 | 09000064868a2f09 | |||
| FDA-2022-N-2390-0106 | FDA | FDA-2022-N-2390 | Exhibit 217 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:32:11Z | 0 | 0 | 09000064868a2f0a | |||
| FDA-2022-N-2390-0111 | FDA | FDA-2022-N-2390 | Exhibit 222 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:39Z | 0 | 0 | 09000064868a2f19 | |||
| FDA-2022-N-2390-0113 | FDA | FDA-2022-N-2390 | Exhibit 224 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:26Z | 0 | 0 | 09000064868a2f1b | |||
| FDA-2022-N-2390-0079 | FDA | FDA-2022-N-2390 | Exhibit 190 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:27:08Z | 0 | 0 | 09000064868a27cf | |||
| FDA-2022-N-2390-0084 | FDA | FDA-2022-N-2390 | Exhibit 195 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:28:11Z | 0 | 0 | 09000064868a28ff | |||
| FDA-2022-N-2390-0098 | FDA | FDA-2022-N-2390 | Exhibit 209 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:29:59Z | 0 | 0 | 09000064868a2ef1 | |||
| FDA-2022-N-2390-0074 | FDA | FDA-2022-N-2390 | Index to Exhibits | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:25:42Z | 0 | 0 | 09000064868a4593 | |||
| FDA-2022-N-2390-0080 | FDA | FDA-2022-N-2390 | Exhibit 191 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:27:13Z | 0 | 0 | 09000064868a28fb | |||
| FDA-2024-H-5925-0001 | FDA | FDA-2024-H-5925 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-02T05:00:00Z | 2025-01-02T14:58:24Z | 0 | 0 | 090000648689756a | ||
| FDA-2024-H-5800-0001 | FDA | FDA-2024-H-5800 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-02T05:00:00Z | 2025-01-02T15:04:04Z | 0 | 0 | 0900006486898448 | ||
| FDA-2024-H-5916-0001 | FDA | FDA-2024-H-5916 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-02T05:00:00Z | 2025-01-02T15:11:03Z | 0 | 0 | 0900006486898d43 | ||
| FDA-2024-H-5928-0001 | FDA | FDA-2024-H-5928 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-02T05:00:00Z | 2025-01-02T14:04:26Z | 0 | 0 | 0900006486897071 | ||
| FDA-2024-H-5920-0001 | FDA | FDA-2024-H-5920 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2024-12-31T15:13:15Z | 0 | 0 | 09000064868968ce | ||
| FDA-2024-H-5922-0001 | FDA | FDA-2024-H-5922 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2024-12-31T15:54:19Z | 0 | 0 | 0900006486897104 | ||
| FDA-2024-N-2980-0006 | FDA | FDA-2024-N-2980 | Evaluating the Immunogenicity Risk of Host Cell Proteins in Follow-On Recombinant Peptide Products; Reopening of the Comment Period | Notice | Extension of Comment Period | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2024-12-31T14:48:35Z | 2024-31365 | 0 | 0 | 0900006486896ad4 | |
| FDA-2024-H-5924-0001 | FDA | FDA-2024-H-5924 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-02T05:00:00Z | 2025-01-02T14:57:26Z | 0 | 0 | 090000648689754d | ||
| FDA-2022-N-2390-0085 | FDA | FDA-2022-N-2390 | Exhibit 196 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:28:17Z | 0 | 0 | 09000064868a3100 | |||
| FDA-2022-N-2390-0100 | FDA | FDA-2022-N-2390 | Exhibit 211 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:30:11Z | 0 | 0 | 09000064868a2f04 | |||
| FDA-2022-N-2390-0102 | FDA | FDA-2022-N-2390 | Exhibit 213 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:32:32Z | 0 | 0 | 09000064868a2f06 | |||
| FDA-2022-N-2390-0104 | FDA | FDA-2022-N-2390 | Exhibit 215 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:32:23Z | 0 | 0 | 09000064868a2f08 | |||
| FDA-2022-N-2390-0112 | FDA | FDA-2022-N-2390 | Exhibit 223 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:32Z | 0 | 0 | 09000064868a2f1a | |||
| FDA-2022-N-2390-0114 | FDA | FDA-2022-N-2390 | Exhibit 225 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:20Z | 0 | 0 | 09000064868a2f1c | |||
| FDA-2022-N-2390-0117 | FDA | FDA-2022-N-2390 | Exhibit 228 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:03Z | 0 | 0 | 09000064868a2f1f | |||
| FDA-2024-H-5931-0001 | FDA | FDA-2024-H-5931 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-02T05:00:00Z | 2025-01-02T14:48:56Z | 0 | 0 | 09000064868971c7 | ||
| FDA-2024-H-5917-0001 | FDA | FDA-2024-H-5917 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-02T05:00:00Z | 2025-01-02T15:11:54Z | 0 | 0 | 0900006486898d49 | ||
| FDA-2022-N-2390-0083 | FDA | FDA-2022-N-2390 | Exhibit 194 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:27:40Z | 0 | 0 | 09000064868a28fe | |||
| FDA-2022-N-2390-0094 | FDA | FDA-2022-N-2390 | Exhibit 205 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:29:37Z | 0 | 0 | 09000064868a2eed | |||
| FDA-2022-N-2390-0089 | FDA | FDA-2022-N-2390 | Exhibit 200 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:28:58Z | 0 | 0 | 09000064868a3104 | |||
| FDA-2022-N-2390-0075 | FDA | FDA-2022-N-2390 | Exhibit 186 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:25:49Z | 0 | 0 | 09000064868a27cb | |||
| FDA-2022-N-2390-0076 | FDA | FDA-2022-N-2390 | Exhibit 187 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:25:55Z | 0 | 0 | 09000064868a27cc | |||
| FDA-2022-N-2390-0099 | FDA | FDA-2022-N-2390 | Exhibit 210 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:30:05Z | 0 | 0 | 09000064868a2ef2 | |||
| FDA-2022-N-2390-0124 | FDA | FDA-2022-N-2390 | Exhibit 235 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:26:49Z | 0 | 0 | 09000064868a2f33 | |||
| FDA-2022-N-2390-0122 | FDA | FDA-2022-N-2390 | Exhibit 233 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:30:36Z | 0 | 0 | 09000064868a2f31 | |||
| FDA-2022-N-2390-0109 | FDA | FDA-2022-N-2390 | Exhibit 220 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:53Z | 0 | 0 | 09000064868a2f0d | |||
| FDA-2024-H-5918-0001 | FDA | FDA-2024-H-5918 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2024-12-31T14:00:47Z | 0 | 0 | 090000648689688b | ||
| FDA-2024-H-5867-0001 | FDA | FDA-2024-H-5867 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2024-12-31T14:43:58Z | 0 | 0 | 09000064868968a8 | ||
| FDA-2024-N-5830-0001 | FDA | FDA-2024-N-5830 | Advisory Committee; Dermatologic and Ophthalmic Drugs Advisory Committee; Renewal | Notice | Notice of Renewal | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2024-12-31T14:00:03Z | 2024-31363 | 0 | 0 | 0900006486896cc5 | |
| FDA-2024-H-5926-0001 | FDA | FDA-2024-H-5926 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-02T05:00:00Z | 2025-01-02T14:59:14Z | 0 | 0 | 090000648689758c | ||
| FDA-2024-H-5915-0001 | FDA | FDA-2024-H-5915 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-02T05:00:00Z | 2025-01-02T15:09:09Z | 0 | 0 | 09000064868984fb | ||
| FDA-2024-H-5832-0001 | FDA | FDA-2024-H-5832 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-02T05:00:00Z | 2025-01-02T15:07:02Z | 0 | 0 | 090000648689844e | ||
| FDA-2022-N-2390-0086 | FDA | FDA-2022-N-2390 | Exhibit 197 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:28:27Z | 0 | 0 | 09000064868a3101 | |||
| FDA-2022-N-2390-0092 | FDA | FDA-2022-N-2390 | Exhibit 203 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:29:18Z | 0 | 0 | 09000064868a2eeb | |||
| FDA-2022-N-2390-0095 | FDA | FDA-2022-N-2390 | Exhibit 206 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:29:43Z | 0 | 0 | 09000064868a2eee | |||
| FDA-2022-N-2390-0129 | FDA | FDA-2022-N-2390 | Exhibit 240 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:26:19Z | 0 | 0 | 09000064868a2f38 | |||
| FDA-2022-N-2390-0093 | FDA | FDA-2022-N-2390 | Exhibit 204 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:29:32Z | 0 | 0 | 09000064868a2eec | |||
| FDA-2022-N-2390-0116 | FDA | FDA-2022-N-2390 | Exhibit 227 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:09Z | 0 | 0 | 09000064868a2f1e | |||
| FDA-2022-N-2390-0118 | FDA | FDA-2022-N-2390 | Exhibit 229 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:30:57Z | 0 | 0 | 09000064868a2f20 | |||
| FDA-2022-N-2390-0110 | FDA | FDA-2022-N-2390 | Exhibit 221 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:47Z | 0 | 0 | 09000064868a2f18 | |||
| FDA-2022-N-2390-0121 | FDA | FDA-2022-N-2390 | Exhibit 232 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:30:41Z | 0 | 0 | 09000064868a2f30 | |||
| FDA-2024-H-5923-0001 | FDA | FDA-2024-H-5923 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2024-12-31T16:22:10Z | 0 | 0 | 0900006486897134 | ||
| FDA-2024-H-5919-0001 | FDA | FDA-2024-H-5919 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T05:00:00Z | 2024-12-31T15:50:42Z | 0 | 0 | 09000064868968fe | ||
| FDA-2024-H-5930-0001 | FDA | FDA-2024-H-5930 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-02T05:00:00Z | 2025-01-02T14:33:28Z | 0 | 0 | 090000648689751e | ||
| FDA-2024-H-5914-0001 | FDA | FDA-2024-H-5914 | Complaint | Other | Complaint | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-02T05:00:00Z | 2025-01-02T15:08:06Z | 0 | 0 | 0900006486898496 | ||
| FDA-2022-N-2390-0078 | FDA | FDA-2022-N-2390 | Exhibit 189 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:26:07Z | 0 | 0 | 09000064868a27ce | |||
| FDA-2022-N-2390-0091 | FDA | FDA-2022-N-2390 | Exhibit 202 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:29:10Z | 0 | 0 | 09000064868a2eea | |||
| FDA-2022-N-2390-0125 | FDA | FDA-2022-N-2390 | Exhibit 236 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:26:43Z | 0 | 0 | 09000064868a2f34 | |||
| FDA-2022-N-2390-0077 | FDA | FDA-2022-N-2390 | Exhibit 188 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:26:01Z | 0 | 0 | 09000064868a27cd | |||
| FDA-2022-N-2390-0081 | FDA | FDA-2022-N-2390 | Exhibit 192 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:27:20Z | 0 | 0 | 09000064868a28fc | |||
| FDA-2022-N-2390-0087 | FDA | FDA-2022-N-2390 | Exhibit 198 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:28:46Z | 0 | 0 | 09000064868a3102 | |||
| FDA-2022-N-2390-0082 | FDA | FDA-2022-N-2390 | Exhibit 193 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:27:25Z | 0 | 0 | 09000064868a28fd | |||
| FDA-2022-N-2390-0119 | FDA | FDA-2022-N-2390 | Exhibit 230 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:30:51Z | 0 | 0 | 09000064868a2f21 | |||
| FDA-2022-N-2390-0108 | FDA | FDA-2022-N-2390 | Exhibit 219 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:58Z | 0 | 0 | 09000064868a2f0c | |||
| FDA-2016-E-4588-0006 | FDA | FDA-2016-E-4588 | Determination of Regulatory Review Period for Purposes of Patent Extension; XTAMPZA ER | Notice | Determinations | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T05:00:00Z | 2025-03-01T04:59:59Z | 2025-02-24T02:00:23Z | 2024-31023 | 0 | 0 | 0900006486894b77 |
| FDA-2024-H-5887-0001 | FDA | FDA-2024-H-5887 | Complaint | Other | Complaint | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T05:00:00Z | 2024-12-30T15:16:52Z | 0 | 0 | 0900006486894a3c | ||
| FDA-2024-H-5897-0001 | FDA | FDA-2024-H-5897 | Complaint | Other | Complaint | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T05:00:00Z | 2024-12-30T15:21:32Z | 0 | 0 | 09000064868944b8 | ||
| FDA-2023-N-4597-0003 | FDA | FDA-2023-N-4597 | Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Shortages Data Collection | Notice | Notice of Approval | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T05:00:00Z | 2024-12-30T16:46:09Z | 2024-31025 | 0 | 0 | 0900006486894ecc | |
| FDA-2024-D-5580-0001 | FDA | FDA-2024-D-5580 | M15 General Principles for Model- Informed Drug Development; International Council for Harmonisation; Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T05:00:00Z | 2024-12-30T16:48:34Z | 2024-31027 | 0 | 0 | 0900006486894ec6 | |
| FDA-2024-N-3248-0002 | FDA | FDA-2024-N-3248 | Fosun Pharma USA Inc., et al.; Withdrawal of Approval of 23 Abbreviated New Drug Applications; Correction | Notice | Correction | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T05:00:00Z | 2024-12-30T16:31:46Z | 2024-31307 | 0 | 0 | 0900006486894fe2 | |
| FDA-2024-H-5901-0001 | FDA | FDA-2024-H-5901 | Complaint | Other | Complaint | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T05:00:00Z | 2024-12-30T18:42:02Z | 0 | 0 | 0900006486895a36 | ||
| FDA-2023-D-5016-0002 | FDA | FDA-2023-D-5016 | Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices; Guidance for Industry - Draft Guidance | Other | Guidance | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T05:00:00Z | 2025-03-01T04:59:59Z | 2025-10-16T09:00:23Z | 1 | 0 | 0900006486894c0f | |
| FDA-2024-H-5904-0001 | FDA | FDA-2024-H-5904 | Complaint | Other | Complaint | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T05:00:00Z | 2024-12-30T21:07:38Z | 0 | 0 | 0900006486894bbe | ||
| FDA-2024-N-0008-0018 | FDA | FDA-2024-N-0008 | Request for Nominations for Individuals and Consumer Organizations for Advisory Committees | Notice | Request for Nominations | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T05:00:00Z | 2024-12-30T15:53:25Z | 2024-31270 | 0 | 0 | 09000064868951c3 | |
| FDA-2024-N-5702-0001 | FDA | FDA-2024-N-5702 | Transfer of Regulatory Responsibility From the Center for Devices and Radiological Health to the Center for Biologics Evaluation and Research; Medical Maggots and Medicinal Leeches | Notice | Announcement | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T05:00:00Z | 2024-12-30T15:46:44Z | 2024-31266 | 0 | 0 | 09000064868951c6 | |
| FDA-2024-N-0846-0003 | FDA | FDA-2024-N-0846 | Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; National Agriculture and Food Defense Strategy Survey | Notice | Notice of Approval | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T05:00:00Z | 2024-12-30T15:00:00Z | 2024-31298 | 0 | 0 | 090000648689526c | |
| FDA-2024-E-0302-0008 | FDA | FDA-2024-E-0302 | Determination of Regulatory Review Period for Purposes of Patent Extension; VEOZAH | Notice | Determinations | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T05:00:00Z | 2025-03-01T04:59:59Z | 2024-12-30T17:41:51Z | 2024-31269 | 0 | 0 | 0900006486894bff |
| FDA-2024-D-4490-0002 | FDA | FDA-2024-D-4490 | Combined FDA and Sponsor Oncologic Drugs Advisory Committee Briefing Document; Guidance for Industry - Draft Guidance | Other | Guidance | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T05:00:00Z | 2025-03-01T04:59:59Z | 2025-03-01T02:00:35Z | 1 | 0 | 09000064868954be | |
| FDA-2024-H-5888-0001 | FDA | FDA-2024-H-5888 | Complaint | Other | Complaint | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T05:00:00Z | 2024-12-30T11:18:50Z | 0 | 0 | 09000064868916c3 | ||
| FDA-2024-N-2149-0002 | FDA | FDA-2024-N-2149 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; De Novo Classification Process (Evaluation of Automatic Class III Designation) | Notice | 30 Day Proposed Information Collection | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T05:00:00Z | 2025-01-30T04:59:59Z | 2024-12-30T16:29:16Z | 2024-31014 | 0 | 0 | 090000648689502a |
| FDA-2022-D-1562-0008 | FDA | FDA-2022-D-1562 | E11A Pediatric Extrapolation; Guidance for Industry | Other | Guidance | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T05:00:00Z | 2024-12-30T16:40:14Z | 1 | 0 | 0900006486895553 | ||
| FDA-2024-H-5903-0001 | FDA | FDA-2024-H-5903 | Complaint | Other | Complaint | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T05:00:00Z | 2024-12-30T16:31:13Z | 0 | 0 | 09000064868944be | ||
| FDA-2024-H-5899-0001 | FDA | FDA-2024-H-5899 | Complaint | Other | Complaint | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T05:00:00Z | 2024-12-30T19:40:49Z | 0 | 0 | 0900006486895a7c | ||
| FDA-2024-E-0299-0008 | FDA | FDA-2024-E-0299 | Determination of Regulatory Review Period for Purposes of Patent Extension; VEOZAH | Notice | Determinations | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T05:00:00Z | 2025-03-01T04:59:59Z | 2024-12-30T17:37:48Z | 2024-31269 | 0 | 0 | 0900006486894779 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);